Adult Oligodendroglioma
20
0
0
13
Key Insights
Highlights
Success Rate
68% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 74/100
30.0%
6 terminated out of 20 trials
68.4%
-18.1% vs benchmark
0%
0 trials in Phase 3/4
62%
8 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (20)
Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
Stereotactic Radiosurgery in Treating Patients With Brain Tumors
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas
Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma
Everolimus in Treating Patients With Recurrent Low-Grade Glioma
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
Yoga Therapy in Treating Patients With Malignant Brain Tumors
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases
18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
Sunitinib in Treating Patients With Recurrent Malignant Gliomas
RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma